David Vicente
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Luis Paz‐AresAli TafreshiJulien MazièresYing ChengJerónimo Rafael Rodríguez‐CidBalázs HalmosAndrew RobinsonKi Hyeong Lee
- Topics
- Cancer Immunotherapy and Biomarkers (23 papers)Lung Cancer Treatments and Mutations (20 papers)Lung Cancer Research Studies (9 papers)
- Partner nations
- SpainUnited StatesJapan
In The Last Decade
David Vicente
44 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 856
- Immunology 225
- Molecular Biology 182
- Cancer Research 159
Countries citing papers authored by David Vicente
This map shows the geographic impact of David Vicente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vicente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vicente more than expected).
Fields of papers citing papers by David Vicente
This network shows the impact of papers produced by David Vicente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vicente. The network helps show where David Vicente may publish in the future.
Co-authorship network of co-authors of David Vicente
This figure shows the co-authorship network connecting the top 25 collaborators of David Vicente. A scholar is included among the top collaborators of David Vicente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vicente. David Vicente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 9 | |
| 3 | Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Studybreakdown → | 233 |
| 4 | 1 | |
| 5 | 43 | |
| 6 | 15 | |
| 7 | 30 | |
| 8 | 1 | |
| 9 | 24 | |
| 10 | 8 | |
| 11 | 154 | |
| 12 | A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407breakdown → | 409 |
| 13 | 57 | |
| 14 | 1 | |
| 15 | 2 | |
| 16 | 2 | |
| 17 | 17 | |
| 18 | 12 | |
| 19 | 58 | |
| 20 | 9 |
About David Vicente
David Vicente is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (856 citations) and Immunology (225 citations). David Vicente has collaborated with scholars based in Spain, United States and Japan. Frequent co-authors include Luis Paz‐Ares, Ali Tafreshi, Julien Mazières, Ying Cheng, Jerónimo Rafael Rodríguez‐Cid, Balázs Halmos, Andrew Robinson, Ki Hyeong Lee, Bilal Piperdi and Rodryg Ramlau. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.